8 research outputs found
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
<p><b> </b></p>
<p><b>Article full text</b></p><p><br></p><p>The full text of this article can
be found here<b>.</b> <a href="https://link.springer.com/article/10.1007/s40744-018-0102-x">https://link.springer.com/article/10.1007/s40744-018-0102-x</a></p><p></p><p><br></p><p><b>Provide enhanced content for this
article</b></p><p><br></p><p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/âmailto:[email protected]â"><b>[email protected]</b></a>.</p><p><br></p><p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p><p><br></p><p>Other enhanced features include,
but are not limited to:</p><p><br></p><p>• Slide decks</p><p>• Videos and animations</p><p>• Audio abstracts</p><p>
</p><p>• Audio slides</p><p>
</p><p> </p>
<p> </p
Effect of IL-6 inhibition on body weight and adipokine serum levels in human subjects.
<p>Data are expressed as Means ± SEM. * = p<0.05.</p
Effect of IL-6 inhibition on lipoprotein (a) levels in human subjects.
<p>Data are expressed as Means ± SEM of lipoprotein (a) levels x-fold compared to time point 0 month. * = p<0.05.</p
Effect of IL-6 inhibition on insulin sensitivity of human subject.
<p>Data are expressed as Means ± SEM. * = p<0.05.</p
Demographic, anthropometric and clinical characteristics of the study population.
<p>BMI = body mass index, f = female, m = male. Means ± SEM.</p
Metabolic parameters of the study population.
<p>TG = triglycerides, LDL = LDL-cholesterol, HDL = HDL-cholesterol, HbA1c = glycosylated haemoglobin A1c levels.</p>(a)<p> = p<0.05 compared to 0 month,</p>(b)<p> = p<0.05 compared to 0 month. Means ± SEM.</p
Correlation between changes of CRP levels with changes of markers of insulin resistance during the study period.
<p>Spearman Correlation analysis, <i>p</i> = correlation coefficient, P = significances level.</p
Effect of IL-6 inhibition on inflammatory parameters in human subjects.
<p>Data are expressed as Means ± SEM. * = p<0.05.</p